D. Dodds

1.1k total citations
18 papers, 391 citations indexed

About

D. Dodds is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Radiation. According to data from OpenAlex, D. Dodds has authored 18 papers receiving a total of 391 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Pulmonary and Respiratory Medicine, 6 papers in Oncology and 5 papers in Radiation. Recurrent topics in D. Dodds's work include Advanced Radiotherapy Techniques (5 papers), Prostate Cancer Diagnosis and Treatment (4 papers) and Prostate Cancer Treatment and Research (4 papers). D. Dodds is often cited by papers focused on Advanced Radiotherapy Techniques (5 papers), Prostate Cancer Diagnosis and Treatment (4 papers) and Prostate Cancer Treatment and Research (4 papers). D. Dodds collaborates with scholars based in United Kingdom and Italy. D. Dodds's co-authors include Amit Bahl, Robert Huddart, Heather Payne, Catherine Heath, Prashant Patel, Andrew Adamson, R. McMenemin, R Rampling, John L. Peters and T. J. Murray and has published in prestigious journals such as Annals of Internal Medicine, Annals of Oncology and British Journal of Haematology.

In The Last Decade

D. Dodds

15 papers receiving 359 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
D. Dodds United Kingdom	9	88	88	72	72	58	18	391
Hyunnam Ryu South Korea	9	36 0.4×	96 1.1×	22 0.3×	24 0.3×	97 1.7×	29	374
Consuelo Mancías‐Guerra Mexico	11	48 0.5×	75 0.9×	41 0.6×	31 0.4×	170 2.9×	31	436
Catherine L. Miller United States	13	35 0.4×	91 1.0×	27 0.4×	85 1.2×	47 0.8×	25	393
Pierangela De Biasio Italy	17	26 0.3×	216 2.5×	22 0.3×	31 0.4×	43 0.7×	44	738
Dirk F. Richter Germany	14	242 2.8×	307 3.5×	29 0.4×	28 0.4×	84 1.4×	34	687
Marcelina G. Perez United States	9	29 0.3×	84 1.0×	13 0.2×	17 0.2×	91 1.6×	10	280
Oskar Gustafsson Sweden	12	65 0.7×	55 0.6×	43 0.6×	136 1.9×	8 0.1×	24	447
Hai Jiang China	11	95 1.1×	142 1.6×	44 0.6×	67 0.9×	9 0.2×	45	383
Chiara Cugno Qatar	13	98 1.1×	117 1.3×	17 0.2×	21 0.3×	189 3.3×	33	644
Ron Auslender Israel	17	92 1.0×	264 3.0×	36 0.5×	50 0.7×	37 0.6×	68	1.2k

Countries citing papers authored by D. Dodds

Since Specialization

Citations

This map shows the geographic impact of D. Dodds's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by D. Dodds with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites D. Dodds more than expected).

Fields of papers citing papers by D. Dodds

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by D. Dodds. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by D. Dodds. The network helps show where D. Dodds may publish in the future.

Co-authorship network of co-authors of D. Dodds

This figure shows the co-authorship network connecting the top 25 collaborators of D. Dodds. A scholar is included among the top collaborators of D. Dodds based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with D. Dodds. D. Dodds is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

18 of 18 papers shown

1.

Cartwright, Douglas, Alistair S. McLaren, Mark White, et al.. (2025). 109P Neoadjuvant immunotherapy in locally advanced mismatch repair-deficient colon cancer: The west of Scotland experience. Annals of Oncology. 36. S50–S51.

2.

Dodds, D., Azmat Sadozye, Philip McLoone, et al.. (2020). Dosimetric impact of organ at risk daily variation during prostate stereotactic ablative radiotherapy. British Journal of Radiology. 93(1108). 20190789–20190789. 8 indexed citations

3.

Duffton, Aileen, Azmat Sadozye, Nicholas MacLeod, et al.. (2018). Safety and feasibility of prostate stereotactic ablative radiotherapy using multimodality imaging and flattening filter free. British Journal of Radiology. 91(1084). 20170625–20170625. 6 indexed citations

4.

McKay, Stephen, S. Neilson, Jan Wallace, et al.. (2017). Real‐world uptake, safety profile and outcomes of docetaxel in newly diagnosed metastatic prostate cancer. British Journal of Urology. 121(2). 268–274. 18 indexed citations

5.

Banfill, Kathryn, Aileen Duffton, & D. Dodds. (2016). Radiotherapy for patients with prostate cancer. Cancer Nursing Practice. 15(1). 27–33.

6.

Duffton, Aileen, et al.. (2015). EP-1672: Feasibility, safety and efficiency of delivering prostate SABR using flattening filter free VMAT. Radiotherapy and Oncology. 115. S916–S916. 1 indexed citations

7.

Thompson, Anne, Andrew Adamson, Amit Bahl, et al.. (2013). Guidelines for the diagnosis, prevention and management of chemical- and radiation-induced cystitis. Journal of Clinical Urology. 7(1). 25–35. 20 indexed citations

8.

Payne, Heather, Andrew Adamson, Amit Bahl, et al.. (2013). Chemical‐ and radiation‐induced haemorrhagic cystitis: current treatments and challenges. British Journal of Urology. 112(7). 885–897. 96 indexed citations

9.

Dodds, D., et al.. (2004). Prostate Brachytherapy: An Option in the Treatment of Early Stage Prostate Cancer. 4(2). 53–69.

10.

Watts, Michael, Stuart J. Ings, Michael Flynn, et al.. (2000). Remobilization of patients who fail to achieve minimal progenitor thresholds at the first attempt is clinically worthwhile. British Journal of Haematology. 111(1). 287–291. 27 indexed citations

11.

Watts, Michael, Stuart J. Ings, Michael Flynn, et al.. (2000). Remobilization of patients who fail to achieve minimal progenitor thresholds at the first attempt is clinically worthwhile. British Journal of Haematology. 111(1). 287–291. 13 indexed citations

12.

Watts, MJ, et al.. (1999). Remobilization of poor stem cell mobilizers is clinically worthwhile.. UCL Discovery (University College London). 2 indexed citations

13.

Dodds, D., et al.. (1997). Liposomal distribution in malignant glioma. Nuclear Medicine Communications. 18(1). 17–23. 39 indexed citations

14.

Dodds, D., et al.. (1997). Central neurocytoma: A clinical study of response to chemotherapy. Journal of Neuro-Oncology. 34(3). 279–283. 43 indexed citations

15.

Dodds, D., R.P. Symonds, C. Deehan, et al.. (1996). A linear quadratic analysis of gynaecological brachytherapy. Clinical Oncology. 8(2). 90–96. 4 indexed citations

16.

Miller, Andrea, David Klaaßen, D. A. Boyes, et al.. (1980). Combination v. sequential therapy with melphalan, 5-fluorouracil and methotrexate for advanced ovarian cancer.. PubMed. 123(5). 365–71. 11 indexed citations

17.

Miller, A. B., Harold E. Taylor, M. A. Baker, et al.. (1979). Oral administration of BCG as an adjuvant to surgical treatment of carcinoma of the bronchus.. PubMed. 121(1). 45–54. 8 indexed citations

18.

Dodds, D.. (1968). Familiar Medical Quotations.. Annals of Internal Medicine. 69(5). 1078–1079. 95 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact